Remove BioTech Remove Drug Development Remove Medical Technology
article thumbnail

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Digital Health Global

We believe our pioneering technology will allow us to shatter the boundaries that exist in gene editing methods today,” said Anne-K. Both Wellington and Forbion are visionaries and highly experienced biotech investors, and we look forward to working closely with them in our efforts to transform the gene editing landscape.” “Our

article thumbnail

Q&A with Rami Rajab and Inna Nadelwais, Mecomed

Healthcare Innovation Consortium

We aim to bring together relevant stakeholders, including payers, providers, patients groups, and biotech and when and where needed we cooperate with pharma, to be the one voice of the industry. Inna: Our aim is to improve patient and clinician access to modern, innovative and reliable medical technology.

BioTech 60
article thumbnail

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

Recent Examples of VC Investment in Wound Care: Corryn Biotechnologies: This UK-based startup raised £550,000 in seed funding to develop a novel wound dressing technology. Clinical Trials: Conducting clinical trials to demonstrate the safety and efficacy of new wound care products and technologies can be expensive and time-consuming.